Concepts (93)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Infant, Premature | 6 | 2021 | 872 | 0.620 |
Why?
|
| Perinatology | 1 | 2016 | 32 | 0.460 |
Why?
|
| Umbilical Cord | 1 | 2016 | 56 | 0.450 |
Why?
|
| Bronchopulmonary Dysplasia | 2 | 2014 | 222 | 0.370 |
Why?
|
| Tracheostomy | 1 | 2012 | 212 | 0.300 |
Why?
|
| Fetal Diseases | 2 | 2024 | 440 | 0.270 |
Why?
|
| Urethral Obstruction | 2 | 2024 | 56 | 0.190 |
Why?
|
| Delphi Technique | 1 | 2024 | 283 | 0.190 |
Why?
|
| Infant, Newborn | 9 | 2023 | 8635 | 0.180 |
Why?
|
| Ultrasonography, Prenatal | 2 | 2024 | 986 | 0.160 |
Why?
|
| Infant, Extremely Premature | 1 | 2021 | 113 | 0.160 |
Why?
|
| Urologic Diseases | 1 | 2019 | 42 | 0.150 |
Why?
|
| Spinal Dysraphism | 1 | 2023 | 261 | 0.150 |
Why?
|
| Hyaline Membrane Disease | 1 | 1998 | 4 | 0.140 |
Why?
|
| Ureaplasma | 1 | 2018 | 8 | 0.140 |
Why?
|
| Ureaplasma Infections | 1 | 2018 | 9 | 0.140 |
Why?
|
| Pulmonary Surfactants | 1 | 1998 | 45 | 0.140 |
Why?
|
| Positive-Pressure Respiration | 1 | 1998 | 84 | 0.140 |
Why?
|
| Premature Birth | 1 | 2023 | 428 | 0.140 |
Why?
|
| Respiration | 1 | 2018 | 117 | 0.130 |
Why?
|
| Continuous Positive Airway Pressure | 1 | 2018 | 63 | 0.130 |
Why?
|
| Constriction | 1 | 2016 | 46 | 0.120 |
Why?
|
| Polycythemia | 1 | 2016 | 46 | 0.120 |
Why?
|
| History, 18th Century | 1 | 2016 | 68 | 0.120 |
Why?
|
| World Health Organization | 1 | 2016 | 118 | 0.110 |
Why?
|
| Severity of Illness Index | 2 | 2014 | 3061 | 0.110 |
Why?
|
| History, 21st Century | 1 | 2016 | 263 | 0.110 |
Why?
|
| History, 20th Century | 1 | 2016 | 365 | 0.100 |
Why?
|
| Fetofetal Transfusion | 1 | 2016 | 206 | 0.100 |
Why?
|
| Combined Modality Therapy | 2 | 2012 | 1216 | 0.100 |
Why?
|
| Anemia | 1 | 2016 | 354 | 0.090 |
Why?
|
| Respiratory Therapy | 1 | 2012 | 19 | 0.090 |
Why?
|
| Gestational Age | 3 | 2023 | 1224 | 0.090 |
Why?
|
| Follow-Up Studies | 3 | 2021 | 5196 | 0.090 |
Why?
|
| Time Factors | 3 | 2018 | 6196 | 0.090 |
Why?
|
| Respiration, Artificial | 1 | 2014 | 501 | 0.080 |
Why?
|
| Infant | 5 | 2021 | 13352 | 0.080 |
Why?
|
| Teichoic Acids | 1 | 2009 | 9 | 0.070 |
Why?
|
| Staphylococcus epidermidis | 1 | 2009 | 39 | 0.070 |
Why?
|
| Pregnancy | 4 | 2024 | 7512 | 0.070 |
Why?
|
| Retrospective Studies | 5 | 2023 | 17753 | 0.070 |
Why?
|
| Lipopolysaccharides | 1 | 2009 | 299 | 0.060 |
Why?
|
| Female | 10 | 2024 | 70963 | 0.060 |
Why?
|
| Humans | 12 | 2024 | 131163 | 0.060 |
Why?
|
| Neutrophils | 1 | 2009 | 371 | 0.060 |
Why?
|
| Fetoscopy | 2 | 2023 | 460 | 0.060 |
Why?
|
| Staphylococcus aureus | 1 | 2009 | 483 | 0.060 |
Why?
|
| Staphylococcal Infections | 1 | 2009 | 571 | 0.050 |
Why?
|
| Male | 7 | 2024 | 64957 | 0.050 |
Why?
|
| Urinary Bladder | 1 | 2024 | 220 | 0.050 |
Why?
|
| Antibodies, Monoclonal | 1 | 2009 | 981 | 0.050 |
Why?
|
| Cervix Uteri | 1 | 2023 | 57 | 0.050 |
Why?
|
| Anti-Bacterial Agents | 2 | 2018 | 2596 | 0.050 |
Why?
|
| Laparotomy | 1 | 2023 | 138 | 0.040 |
Why?
|
| Carbon Dioxide | 1 | 2023 | 270 | 0.040 |
Why?
|
| Treatment Outcome | 2 | 2012 | 12936 | 0.040 |
Why?
|
| Infant Mortality | 1 | 2021 | 183 | 0.040 |
Why?
|
| Perinatal Mortality | 1 | 2019 | 44 | 0.040 |
Why?
|
| Oligohydramnios | 1 | 2019 | 46 | 0.040 |
Why?
|
| Pregnancy Trimester, Second | 1 | 2019 | 162 | 0.040 |
Why?
|
| Amniotic Fluid | 1 | 2019 | 147 | 0.030 |
Why?
|
| Physical Exertion | 1 | 2018 | 63 | 0.030 |
Why?
|
| Ampicillin | 1 | 2018 | 59 | 0.030 |
Why?
|
| Pressure | 1 | 2018 | 117 | 0.030 |
Why?
|
| Gentamicins | 1 | 2018 | 88 | 0.030 |
Why?
|
| Data Interpretation, Statistical | 1 | 1998 | 226 | 0.030 |
Why?
|
| Area Under Curve | 1 | 2018 | 304 | 0.030 |
Why?
|
| Developmental Disabilities | 1 | 2021 | 781 | 0.030 |
Why?
|
| Analysis of Variance | 1 | 2018 | 928 | 0.030 |
Why?
|
| Linear Models | 1 | 2018 | 688 | 0.030 |
Why?
|
| Esophagus | 1 | 2018 | 258 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 1 | 2018 | 1447 | 0.030 |
Why?
|
| Prognosis | 1 | 2024 | 4886 | 0.030 |
Why?
|
| Pregnancy, Twin | 1 | 2016 | 191 | 0.030 |
Why?
|
| Ultrasonography | 1 | 2019 | 943 | 0.030 |
Why?
|
| Heart Rate | 1 | 2018 | 577 | 0.030 |
Why?
|
| Child, Preschool | 2 | 2021 | 15110 | 0.030 |
Why?
|
| Ohio | 1 | 2014 | 85 | 0.030 |
Why?
|
| Infant, Very Low Birth Weight | 1 | 2014 | 176 | 0.020 |
Why?
|
| Incidence | 1 | 2018 | 3360 | 0.020 |
Why?
|
| Intensive Care Units, Neonatal | 1 | 2014 | 361 | 0.020 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2019 | 853 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2019 | 3711 | 0.020 |
Why?
|
| Serum Bactericidal Test | 1 | 2009 | 1 | 0.020 |
Why?
|
| Half-Life | 1 | 2009 | 149 | 0.020 |
Why?
|
| Injections, Intravenous | 1 | 2009 | 239 | 0.020 |
Why?
|
| Phagocytosis | 1 | 2009 | 190 | 0.020 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2009 | 688 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2009 | 1618 | 0.010 |
Why?
|
| Adult | 2 | 2019 | 31282 | 0.010 |
Why?
|
| Mice | 1 | 2009 | 18301 | 0.010 |
Why?
|
| Middle Aged | 1 | 2009 | 28601 | 0.000 |
Why?
|
| Animals | 1 | 2009 | 33912 | 0.000 |
Why?
|